AIM
MNTA

Alambic Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Alambic Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-34,265
Closed -$579K – 624
2017
Q2 		$579K Sell
34,265
-17,437
-34% -$265K 0.07% 354
2017
Q1 		$690K Buy
51,702
+19,500
+61% +$305K 0.09% 338
2016
Q4 		$485K Sell
32,202
-1,700
-5% -$22.5K 0.09% 336
2016
Q3 		$396K Sell
33,902
-900
-3% -$10.6K 0.09% 325
2016
Q2 		$376K Sell
34,802
-7,700
-18% -$79.4K 0.09% 338
2016
Q1 		$393K Buy
+42,502
New +$457K 0.13% 263

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Alambic Investment Management's MNTA Position: Q3 2017 in Review

Alambic Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 34,265 shares — an estimated $579K sold.

Alambic Investment Management first reported a position in MNTA in Q1 2016 and held it in 6 quarters. The position peaked at $690K in Q1 2017. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

  • Alambic Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Alambic Investment Management sold 34,265 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $579K.
  • Alambic Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2016 and held it in 6 quarters.
  • Alambic Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $690K in Q1 2017.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on Alambic Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.